- Clear All
- Remove thePolicyfilter Policy
- Remove theInternal medicinefilter Internal medicine
- Remove theToxicologyfilter Toxicology
- Remove theAVMA policyfilter AVMA policy
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theProduction medicinefilter Production medicine
Your search for 'Production medicine' has returned 4 results
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…